11 matokeo
BACKGROUND OF THE INVENTION
Field of the Invention
The present invention is in the field of cancer biology and pharmacotherapy of cancer diseases and conditions. More specifically, the present invention is giant obscurins and uses thereof.
Description of the Related Art
Obscurins comprise a family
TECHNICAL FIELD
The present invention relates to a prophylactic or therapeutic agent and the like for giant cell tumors occurring in a bone and soft tissue or for chondrosarcoma, in which agent a non-steroidal anti-inflammatory agent or a thiazolidine derivative is used. The present invention also
TECHNICAL FIELD
The present invention relates to an agent for prophylactic treatment, therapeutic treatment, or prevention of metastasis of giant cell tumor occurring in a bone and soft tissue, chondrosarcoma, or bone sarcoma, and the like, which uses a substance having a PPAR.gamma.-agonistic
BACKGROUND OF THE INVENTION
The present invention provides a method for the preparation of novel compositions containing strongly antigenic tumor-specific substances and cancer diagnostic methods utilizing said substances and compositions.
It is known that several human cancers such as melanomas,
CROSS-REFERENCE TO RELATED APPLICATIONS
This U.S. non-provisional patent application claims priority under 35 U.S.C. .sctn.119 of Korean Patent Application No. 10-2012-0153424, filed on Dec. 26, 2012, the entire contents of which are hereby incorporated by reference.
BACKGROUND OF THE INVENTION
The
FIELD OF USE
The present invention is in the field of human transplantation and more particularly in the field of intraocular and intracranial transplantation of specially treated human cells which reestablish neuronal connections between the retina and the ocular cortex, which neurons having been
FIELD OF THE INVENTION
Disclosed are novel compounds and uses thereof. In certain embodiments disclosed compounds are kinase inhibitors.
SUMMARY OF THE INVENTION
In certain aspects and embodiments disclosed herein, compounds are provided, as well as various salts thereof, formulations thereof,
FIELD OF THE INVENTION
Disclosed are novel compounds and uses thereof. In certain embodiments disclosed compounds are kinase inhibitors.
SUMMARY OF THE INVENTION
In certain aspects and embodiments disclosed herein, compounds are provided, as well as various salts thereof, formulations thereof,
FIELD OF THE INVENTION
Disclosed are novel compounds and uses thereof. In certain embodiments disclosed compounds are kinase inhibitors.
SUMMARY OF THE INVENTION
In certain aspects and embodiments disclosed herein, compounds are provided, as well as various salts thereof, formulations thereof,
FIELD OF THE INVENTION
Disclosed are novel compounds and uses thereof. In certain embodiments disclosed compounds are kinase inhibitors.
SUMMARY OF THE INVENTION
In certain aspects and embodiments disclosed herein, compounds are provided, as well as various salts thereof, formulations thereof,
FIELD OF THE INVENTION
Disclosed are novel compounds and uses thereof. In certain embodiments disclosed compounds are kinase inhibitors.
SUMMARY OF THE INVENTION
In certain aspects and embodiments disclosed herein, compounds are provided, as well as various salts thereof, formulations thereof,